Heparin-induced thrombocytopenia and fatal thrombosis in a patient with activated protein C resistance
โ Scribed by J. Gardyn; P. Sorkin; Y. Kluger; S. Kabili; J. M. Klausner; A. Zivelin; Prof A. Eldor
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 367 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Four hundred and ninety-three consecutive patients referred for arterial or venous thrombosis were screened for congenital and acquired abnormalities of blood coagulation predisposing to thrombosis, and were compared to 341 age-and sex-matched controls. The aim of the study was to determine the prev
To determine the prevalence of activated protein C resistance and the factor V Leiden mutation (position 1691, arginine 506 to glutamine substitution) in children with thrombosis, plasma samples from children with thrombosis were tested for activated protein C resistance. DNA was analyzed for the fa
Heparin-induced thrombocytopenia with thrombosis (HITT) can lead to serious morbidity and may be potentially fatal. We reviewed our experience with this entity over a 4-year period, to determine the following: 1) incidence and type of thrombosis in patients with heparin-induced thrombocytopenia (HIT